News
Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.
Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight after 72 weeks in ...
Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount ...
Trials of a daily obesity pill have shown it can help patients lose around 12% of their body weight over 72 weeks. The ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...
Are weight loss shots like Ozempic and Wegovy safe long-term? It’s complicated. Some early studies suggest thyroid concerns ...
But Wegovy may be more effective for weight loss because it’s taken in higher doses than Ozempic. Here’s a run-through of how each medication works and its effectiveness for weight loss.
New trial results show the weight-loss medication Wegovy can also cut heart attack and stroke risks, according to the drug's maker. The maker of Wegovy is claiming the weight loss drug can ...
A new study from McGill University is looking into other uses for some weight loss and diabetes medications. The study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results